Science Explorer Back to mapMap
Institution · Henry Dunant Hospital

Most cited papers from Henry Dunant Hospital

What are the most cited papers from Henry Dunant Hospital?

The most cited paper from Henry Dunant Hospital is "Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report" (Peter Malfertheiner, Françis Mégraud, Colm A O'Morain et al., 2016), with 2,970 citations. Next come "Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C" (2,842) and "Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report" (2,272).

Showing 50 of 60 papers. Every paper with more than 249 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report Peter Malfertheiner, Françis Mégraud, Colm A O'Morain et al. · Gut Open access 5 Oct 2016 2,970
2 Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C Stephanos J. Hadziyannis, Hoel Sette, Timothy R. Morgan et al. · Annals of Internal Medicine 2 Mar 2004 2,842
3 Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report Peter Malfertheiner, Françis Mégraud, Colm A O'Morain et al. · Gut Open access 5 Apr 2012 2,272
4 Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report Peter Malfertheiner, Françis Mégraud, Colm A O'Morain et al. · Gut Open access 14 Dec 2006 2,248
5 Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections M. E. Falagas, S. K. Kasiakou, Louis Donald Saravolatz · Clinical Infectious Diseases 15 Apr 2005 1,749
6 Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report Peter Malfertheiner, Françis Mégraud, Theodore Rokkas et al. · Gut Open access 8 Aug 2022 1,507
7 Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis Georgios Pappas, Nikos Roussos, Matthew E. Falagas · International Journal for Parasitology 10 May 2009 1,188
8 Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B Patrick Marcellin, George K.K. Lau, Ferruccio Bonino et al. · New England Journal of Medicine Open access 15 Sep 2004 1,149
9 Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote et al. · New England Journal of Medicine Open access 26 Feb 2003 1,001
10 Current and Future Treatments in Alzheimer Disease: An Update Konstantina G. Yiannopoulou, Sokratis G. Papageorgiou · Journal of Central Nervous System Disease Open access 2020 981
11 Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote et al. · Gastroenterology Open access 21 Sep 2006 886
12 Obesity and infection Matthew E. Falagas, Maria Kompoti · The Lancet Infectious Diseases 20 Jun 2006 824
13 A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses David Cameron et al. · Breast Cancer Research and Treatment 10 Jan 2008 810
14 Cancer biomarkers: Emerging trends and clinical implications for personalized treatment Antonio Passaro, Maise Al Bakir, Emily G. Hamilton et al. · Cell Open access Mar 2024 658
15 Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review Petros I. Rafailidis, Eleni G. Mourtzoukou, Ioannis C. Varbobitis et al. · Virology Journal ReviewOpen access 27 Mar 2008 644
16 Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial Adrianus Johannes De Langen et al. · The Lancet Open access 7 Feb 2023 609
17 Comparison of SCImago journal rank indicator with journal impact factor Matthew E. Falagas, Vasileios Kouranos, Ricardo Arencibia Jorge et al. · The FASEB Journal 11 Apr 2008 562
18 Hepatitis B e antigen-negative chronic hepatitis B Stephanos J. Hadziyannis, Dimitrios Vassilopoulos · Hepatology Open access Oct 2001 559
19 Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines Lawrence T. Goodnough, Alice G. Maniatis, Peter H. Earnshaw et al. · British Journal of Anaesthesia Open access 10 Dec 2010 545
20 -D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis Drosos E. Karageorgopoulos, Evridiki K. Vouloumanou, Fotinie Ntziora et al. · Clinical Infectious Diseases Review 23 Feb 2011 543
21 Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote et al. · New England Journal of Medicine Open access 29 Jun 2005 537
22 Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study Emmanuel Ekanem et al. · Nature Medicine Open access139 authors Jul 2024 484
23 Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B # † Maurizia Rossana Brunetto, Francesco Moriconi, Ferruccio Bonino et al. · Hepatology Open access 2 Dec 2008 483
24 Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy Donald M. Jensen, Timothy R.M. Morgan, Patrick Marcellin et al. · Hepatology Open access 20 Apr 2006 470
25 Current control and treatment of multidrug-resistant Acinetobacter baumannii infections Drosos E. Karageorgopoulos, Matthew E. Falagas · The Lancet Infectious Diseases 18 Nov 2008 449
26 Informed consent: how much and what do patients understand? Matthew E. Falagas, Ioanna P. Korbila, K. Giannopoulou et al. · The American Journal of Surgery 29 Aug 2009 447
27 Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid Meletios Athanasios Dimopoulos, Efstathios Kastritis, Christina Bamia et al. · Annals of Oncology Open access 10 Aug 2008 440
28 High Tidal Volume and Positive Fluid Balance Are Associated With Worse Outcome in Acute Lung Injury Yasser L. Sakr, Jean‐Louis Vincent, Konrad Reinhart et al. · CHEST Journal Nov 2005 407
29 The Artificial Urinary Sphincter After a Quarter of a Century: A Critical Systematic Review of Its Use in Male Non-neurogenic Incontinence Frank Van der Aa, Marcus John Drake, George R. Kasyan et al. · European Urology Review 23 Nov 2012 395
30 Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population # Amalia Gastaldelli, M. Kozàkovà, Kurt Hφjlund et al. · Hepatology Open access 23 Jan 2009 390
31 Heart Failure in Cardiomyopathies: A Position Paper from the Heart Failure Association of the European Society of Cardiology Petar M Seferovic et al. · European Journal of Heart Failure Open access 16 Apr 2019 389
32 The revival of fosfomycin Argyris S. Michalopoulos, Ioannis G. Livaditis, Vassilios Gougoutas · International Journal of Infectious Diseases Open access 26 Sep 2011 381
33 Adefovir Dipivoxil Therapy for Lamivudine–Resistant Hepatitis B in Pre- and Post-Liver Transplantation Patients Eugene R. Schiff et al. · Hepatology 25 Nov 2003 365
34 Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis Konstantinos Z. Vardakas, Giannoula S. Tansarli, Petros I. Rafailidis et al. · Journal of Antimicrobial Chemotherapy Review 21 Aug 2012 359
35 Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review Matthew E. Falagas, Nikos Roussos, Konstantinos Z. Vardakas · International Journal of Infectious Diseases ReviewOpen access 26 Aug 2010 357
36 Platelet-Rich Plasma Versus Autologous Whole Blood for the Treatment of Chronic Lateral Elbow Epicondylitis Christos Thanasas, George N. Papadimitriou, Charalambos Charalambidis et al. · The American Journal of Sports Medicine 2 Aug 2011 353
37 Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir Stephanos J. Hadziyannis, Vassilios Sevastianos, Irene Rapti et al. · Gastroenterology 31 May 2012 350
38 Extended-spectrum β-lactamase-producing organisms Matthew E. Falagas, Drosos E. Karageorgopoulos · Journal of Hospital Infection 11 Jul 2009 348
39 Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials Konstantinos Z. Vardakas, Georgios L. Voulgaris, Athanasios Maliaros et al. · The Lancet Infectious Diseases Review 5 Nov 2017 344
40 Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B Irene Rapti, Evangelini Dimou, Panayota Mitsoula et al. · Hepatology 26 Jan 2007 325
41 Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a Patrick Marcellin, Ferruccio Bonino, George K.K. Lau et al. · Gastroenterology 20 Mar 2009 316
42 Central Serous Chorioretinopathy and Glucocorticoids Evrydiki A Bouzas, Panagiotis Karadimas, Constantin Jean Pournaras · Survey of Ophthalmology Sep 2002 314
43 Different Mechanisms for Impaired Fasting Glucose and Impaired Postprandial Glucose Tolerance in Humans Christian Meyer, Walkyria de Paula Pimenta, Hans Juergen Woerle et al. · Diabetes Care Open access 27 Jul 2006 313
44 Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research Konstantina G. Yiannopoulou, Aikaterini Anastasiou, Venetia Zachariou et al. · Biomedicines Open access 9 Dec 2019 311
45 Oxidative stress biomarkers responses to physical overtraining: Implications for diagnosis Konstantinos Margonis, Ioannis G. Fatouros, Athanasios Z. Jamurtas et al. · Free Radical Biology and Medicine 25 May 2007 306
46 Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature Matthew E. Falagas, Petros Kopterides · Journal of Hospital Infection Review 7 Jul 2006 305
47 Resistance to polymyxins: Mechanisms, frequency and treatment options Matthew E. Falagas, Petros I. Rafailidis, Dimitrios K. Matthaiou · Drug Resistance Updates 18 Jun 2010 297
48 Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic Argyris S. Michalopoulos, Sotirios Tsiodras, Kostas Rellos et al. · Clinical Microbiology and Infection Open access 26 Jan 2005 292
49 Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE) Andrea C. Ferrari, Dan Stark, Fedro Alessandro Peccatori et al. · ESMO Open Open access Apr 2021 287
50 The optimal imaging of adrenal tumours: a comparison of different methods Ioannis Ilias, Anju Sahdev, Rodney H. Reznek et al. · Endocrine Related Cancer Open access Sep 2007 269

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.